<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-1-90-95</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Оценка эффективности гипотензивной терапии первичной открытоугольной глаукомы по данным паттерн-электроретинограммы</article-title><trans-title-group xml:lang="en"><trans-title>Hypotensive therapy effectiveness evaluation in primary open-angle glaucoma evidenced by pattern electroretinogram data</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6779-4608</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тур</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tur</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Владимировна Тур — канд. мед. наук, доцент, доцент кафедры глазных болезней</p><p>ул. Воровского, д. 64, Челябинск, 454092</p></bio><bio xml:lang="en"><p>Elena V. Tur — Cand. of Med. Sci., assistant professor, assistant professor of chair of eye diseases</p><p>64, Vorovsky St., Chelyabinsk, 454092</p></bio><email xlink:type="simple">elenavtur@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кожевникова</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozhevnikova</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Юрьевна Кожевникова — врач-офтальмолог</p><p>ул. 40-летия Октября, д. 15, Челябинск, 454007</p></bio><bio xml:lang="en"><p>Tatyana Yu. Kozhevnikova — ophthalmologist</p><p>15, 40-letya Oktyabrya St., Chelyabinsk, 454007</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South-Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Медицинская организация "Оптик-Центр"»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Optic-Center Medical Organization</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>03</month><year>2023</year></pub-date><volume>16</volume><issue>1</issue><fpage>90</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тур Е.В., Кожевникова Т.Ю., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Тур Е.В., Кожевникова Т.Ю.</copyright-holder><copyright-holder xml:lang="en">Tur E.V., Kozhevnikova T.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1174">https://roj.igb.ru/jour/article/view/1174</self-uri><abstract><p>Цель работы — оценить изменение функционального состояния ганглиозных клеток сетчатки (ГКС) в ответ на снижение внутриглазного давления (ВГД) у пациентов с впервые выявленной первичной открытоугольной глаукомой (ПОУГ) начальной стадии по данным паттерн-электроретинограммы (ПЭРГ). Материал и методы. Проспективное нерандомизированное когортное исследование включало 12 пациентов (24 глаза), в том числе 5 мужчин и 7 женщин, в возрасте 63,42 ± 2,96 года с впервые выявленной ПОУГ начальной стадии хотя бы на одном глазу, которым кроме комплексного офтальмологического обследования проводили паттерн-электроретинографию (Diopsys Nova, Diopsys, Inc.). Всем пациентам после установления диагноза ПОУГ назначали в качестве монотерапии аналоги простагландинов. Повторные обследования проводились через 1 и 4 мес после начала лечения. Результаты. В указанные сроки отмечено значительное снижение ВГД, которое сопровождалось повышением показателей ПЭРГ, что свидетельствует об улучшении функционирования ГКС. Линейной взаимосвязи между выраженностью снижения ВГД и улучшением параметров ПЭРГ не выявлено. Заключение. У пациентов с начальной стадией ПОУГ при минимальном нарушении со стороны полей зрения по данным пороговой компьютерной периметрии, ранее не получавших лечения, возможно частичное восстановление функциональной активности ГКС при снижении ВГД в результате непрерывной местной гипотензивной терапии аналогами простагландинов. ПЭРГ может являться методом оценки эффективности гипотензивной терапии глаукомы с точки зрения сохранения и улучшения функциональной активности ГКС.</p></abstract><trans-abstract xml:lang="en"><p>Purpose. To evaluate the change in the functional activity of retinal ganglion cells (RGCs) in response to intraocular pressure (IOP) drop in patients with newly diagnosed early stage primary open-angle glaucoma (POAG) using a pattern electroretinogram (PERG). Material and methods. A prospective non-randomized cohort study included 12 patients (24 eyes) including 5 men, 7 women, aged 63.42 ± 2.96 years with newly diagnosed early stage POAG in at least one eye, who underwent PERG (Diopsys Nova, Diopsys, Inc.) in addition to an ophthalmologic examination. After being diagnosed with POAG, all patients were prescribed prostaglandin analogues as monotherapy. One and four months into the treatment, repeated examinations took place. Results. At these time points, a significant decrease in IOP was noted, accompanied by an increase in PERG parameters , which indicates an improvement in the functional activity of RGCs, yet no linear relationship between the IOP decrease and the improvement in PERG parameters could be found. Conclusion. Early stage naïve-treatment POAG patients with minimally impaired visual fields as determined by threshold computer perimetry may have their RGCs functional activity partially restored and IOP lessened thanks to continuous IOP-lowering therapy with prostaglandin analogues. PERG can be used as a method for evaluating the effectiveness of glaucoma hypotensive therapy in terms of maintaining and improving the functional activity of RGCs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первичная открытоугольная глаукома</kwd><kwd>паттерн-электроретинограмма</kwd><kwd>аналоги простагландинов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary open-angle glaucoma</kwd><kwd>pattern electroretinogram</kwd><kwd>POAG</kwd><kwd>PERG</kwd><kwd>prostaglandin analogues</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health; 2021. 9 (2): e144–60. doi: 10.1016/S2214-109X(20)30489-7</mixed-citation><mixed-citation xml:lang="en">Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health; 2021. 9 (2): e144–60. doi: 10.1016/S2214-109X(20)30489-7</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sommer A., Katz J., Quigley H.A., et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991; 109 (1): 77–83. doi: 10.1001/archopht.1991.01080010079037</mixed-citation><mixed-citation xml:lang="en">Sommer A., Katz J., Quigley H.A., et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991; 109 (1): 77–83. doi: 10.1001/archopht.1991.01080010079037</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fry L.E., Fahy E., Chrysostomou V., et. al. The coma in glaucoma: Retinal ganglion cell dysfunction and recovery. Prog Retin Eye Res. 2018; 65: 77–92. doi: 10.1016/j.preteyeres.2018.04.001</mixed-citation><mixed-citation xml:lang="en">Fry L.E., Fahy E., Chrysostomou V., et. al. The coma in glaucoma: Retinal ganglion cell dysfunction and recovery. Prog Retin Eye Res. 2018; 65: 77–92. doi: 10.1016/j.preteyeres.2018.04.001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res. 2012; 31 (6): 702–19. doi: 10.1016/j. preteyeres.2012.07.001</mixed-citation><mixed-citation xml:lang="en">Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res. 2012; 31 (6): 702–19. doi: 10.1016/j. preteyeres.2012.07.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В. Динамика гибели ганглиозных клеток сетчатки при глаукоме и ее функциональные маркеры. Национальный журнал глаукома. 2016; 15 (1): 70–85.</mixed-citation><mixed-citation xml:lang="en">Zueva M.V. Dynamics of retinal ganglion cell death in glaucoma and its functional markers. Russian Journal of Glaucoma. 2016; 15 (1): 70–85 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ventura L.M., Porciatti V. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ophthalmology. 2005; 112 (1): 20–7. doi: 10.1016/j.ophtha.2004.09.002</mixed-citation><mixed-citation xml:lang="en">Ventura L.M., Porciatti V. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ophthalmology. 2005; 112 (1): 20–7. doi: 10.1016/j.ophtha.2004.09.002</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorentini A., Maffei L., Pirchio M., Spinelli D., Porciatti V. The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. Invest. Ophthalmol Vis Sci. 1981; 21 (3): 490–3.</mixed-citation><mixed-citation xml:lang="en">Fiorentini A., Maffei L., Pirchio M., Spinelli D., Porciatti V. The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. Invest. Ophthalmol Vis Sci. 1981; 21 (3): 490–3.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison J.M., O’Connor P.S., Young R.S., Kincaid M., Bentley R. The pattern ERG in man following surgical resection of the optic nerve. Invest. Ophthalmol. Vis. Sci. 1987; 28 (3): 492–9.</mixed-citation><mixed-citation xml:lang="en">Harrison J.M., O’Connor P.S., Young R.S., Kincaid M., Bentley R. The pattern ERG in man following surgical resection of the optic nerve. Invest. Ophthalmol. Vis. Sci. 1987; 28 (3): 492–9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллова М.О., Зуева М.В., Цапенко И.В., Журавлева А.Н. Электрофизиологические маркеры доклинической диагностики глаукомной оптической нейропатии. Российский офтальмологический журнал. 2021; 14 (1): 35–41. https://doi.org/10.21516/2072-0076-2021-14-1-35-41</mixed-citation><mixed-citation xml:lang="en">Kirillova M.O., Zueva M.V., Tsapenko I.V., Zhuravleva A.N. Electrophysiological markers of preclinical diagnosis of glaucomatous optic neuropathy. Russian ophthalmological Journal. 2021; 14 (1): 35–41 (in Russian). https://doi.org/10.21516/2072-0076-2021-14-1-35-41</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bach M. Electrophysiological approaches for early detection of glaucoma. Eur. J. Ophthalmol. 2001; 11(2): 41-9. doi: 10.1177/112067210101102s05</mixed-citation><mixed-citation xml:lang="en">Bach M. Electrophysiological approaches for early detection of glaucoma. Eur. J. Ophthalmol. 2001; 11(2): 41-9. doi: 10.1177/112067210101102s05</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Salgarello T., Giudiceandrea A., Calandriello L., et al. Pattern electroretinogram detects localized glaucoma defects. Translational Vision Science Technology. 2018; 7 (5): 6. doi: 10.1167/tvst.7.5.6</mixed-citation><mixed-citation xml:lang="en">Salgarello T., Giudiceandrea A., Calandriello L., et al. Pattern electroretinogram detects localized glaucoma defects. Translational Vision Science Technology. 2018; 7 (5): 6. doi: 10.1167/tvst.7.5.6</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ventura L.M., Porciatti V. Pattern electroretinogram in glaucoma. Curr. Opin. Ophthalmol. 2006; 17 (2): 196–202. doi: 10.1097/01.icu.0000193082. 44938.3c</mixed-citation><mixed-citation xml:lang="en">Ventura L.M., Porciatti V. Pattern electroretinogram in glaucoma. Curr. Opin. Ophthalmol. 2006; 17 (2): 196–202. doi: 10.1097/01.icu.0000193082. 44938.3c</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cvenkel B., Sustar M., Perovsek D. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectraldomain optical coherence tomography. Doc. Ophthalmol. 2017; 135 (1): 17–28. doi: 10.1007/s10633-017-9595-9</mixed-citation><mixed-citation xml:lang="en">Cvenkel B., Sustar M., Perovsek D. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectraldomain optical coherence tomography. Doc. Ophthalmol. 2017; 135 (1): 17–28. doi: 10.1007/s10633-017-9595-9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Field M.G., Alasil T., Baniasadi N., et al. Facilitating glaucoma diagnosis with inter eye retinal nerve fiber layer asymmetry using spectral-domain optical coherence tomography. J. Glaucoma. 2016; 25 (2): 167–76. doi: 10.1097/ IJG.0000000000000080</mixed-citation><mixed-citation xml:lang="en">Field M.G., Alasil T., Baniasadi N., et al. Facilitating glaucoma diagnosis with inter eye retinal nerve fiber layer asymmetry using spectral-domain optical coherence tomography. J. Glaucoma. 2016; 25 (2): 167–76. doi: 10.1097/ IJG.0000000000000080</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wu, N., Chen, Y., Yang, Y., Sun X. The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST. BMC Ophthalmology. 2020; 20 (1): 422. https://doi.org/10.1186/s12886-020-01693-6</mixed-citation><mixed-citation xml:lang="en">Wu, N., Chen, Y., Yang, Y., Sun X. The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST. BMC Ophthalmology. 2020; 20 (1): 422. https://doi.org/10.1186/ s12886-020-01693-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bolívar G., Sánchez-Barahona C., Teus M., et al. Effect of topical prostaglandin analogues on corneal hysteresis. Acta Ophthalmol. 2015; 93 (6): 495–8. https://doi.org/10.1111/aos.12689</mixed-citation><mixed-citation xml:lang="en">Bolívar G., Sánchez-Barahona C., Teus M., et al. Effect of topical prostaglandin analogues on corneal hysteresis. Acta Ophthalmol. 2015; 93 (6): 495–8. https:// doi.org/10.1111/aos.12689</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lindsey J.D., Crowston J.G., Tran A., Morris C., Weinreb R.N. Direct matrix metalloproteinase enchancement of transscleral permeability. Invest. Ophthalmol. Vis. Sci. 2007; 48 (2): 752–5. doi: 10.1167/iovs.06-0334</mixed-citation><mixed-citation xml:lang="en">Lindsey J.D., Crowston J.G., Tran A., Morris C., Weinreb R.N. Direct matrix metalloproteinase enchancement of transscleral permeability. Invest. Ophthalmol. Vis. Sci. 2007; 48 (2): 752–5. doi: 10.1167/iovs.06-0334</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
